J. Berns

发表

Evidence and implications of haemoglobin cycling in anaemia management.

S. Fishbane, J. Berns, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A survey-based evaluation of self-perceived competency after nephrology fellowship training.

J. Berns, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.

S. Fishbane, J. Berns, Jeffrey S Berns, 2005, Kidney international.

Summary and Comment: Impact of Obstructive Sleep Apnea in Hemodialysis Patients

J. Berns, Stephanie Deloach, 2009, Seminars in dialysis.

Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO.

B. Kasiske, M. Rocco, K. Eckardt, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypoxia-Inducible Factor Stabilization as an Emerging Therapy for CKD-Related Anemia: Report From a Scientific Workshop Sponsored by the National Kidney Foundation.

C. Kovesdy, K. Eckardt, S. Fishbane, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Ultrafiltration Rate Thresholds in Maintenance Hemodialysis: An NKF-KDOQI Controversies Report.

M. Rocco, J. Yee, D. Weiner, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Summary and Comment: That Catheter is Going to Cost You!

J. Berns, 2006 .

That catheter is going to cost you!

J. Berns, 2006, Seminars in dialysis.

Effects of Molidustat in the Treatment of Anemia in CKD.

I. Macdougall, T. Akizawa, J. Berns, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Moving away from hemoglobin-based anemia performance measures in dialysis patients.

J. Berns, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Erythropoiesis-stimulating agents on trial: are higher dosages causing harm?

J. Berns, C. M. Chaknos, 2013, American Journal of Kidney Diseases.

Chapter 7 – Anemia in Chronic Kidney Disease

S. Brunelli, J. Berns, Jeffrey S. Berns, 2010 .

Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?

J. Berns, 2010, Current opinion in nephrology and hypertension.

Summary and Comment: Erythropoietin Bundling: Innovative Remuneration or the Dawn of EPO‐Profiling?

J. Berns, Gbemisola A. Adeseun, 2010, Seminars in dialysis.

Anemia due to Chronic Kidney Disease in the Elderly

J. Berns, 2008 .

Summary and Comment: CHOIR, CREATE, and Anemia Treatment in Patients with CKD

S. Fishbane, J. Berns, 2007, Seminars in dialysis.

IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

J. Adamson, A. Nissenson, P. Deoreo, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review.

M. Rudnick, S. Goldfarb, R. Cohen, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Improving Care of Patients With CKD: The 2015 National Kidney Foundation Presidential Address.

J. Berns, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Should Nephrology Training Programs Continue to Train Fellows in the Placement of Temporary Hemodialysis Catheters?

J. Berns, D. Negoianu, 2014, Seminars in dialysis.

Runner’s Bladder: Exercise-Induced Hematuria With Lower Urinary Tract Pathology

A. Wein, J. Berns, Nicholas A Laryngakis, 2011 .

How Can Erythropoietin Requirements be Reduced in Dialysis Patients?

J. Berns, 2006 .

The renal manifestations of thyroid disease.

L. Mariani, J. Berns, 2012, Journal of the American Society of Nephrology : JASN.

Is angiotensin-converting enzyme inhibitor and angiotensin receptor blocker combination therapy better than monotherapy and safe in patients with CKD?

J. Berns, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Summary and Comment: Activated Vitamin D: Does it Explain an Apparent Survival Advantage among Black and Hispanic Hemodialysis Patients?

J. Berns, T. Tehrani, 2009, Seminars in dialysis.

Addressing Financial Disincentives to Improve CKD Care.

J. Berns, E. Lin, Tonya L Saffer, 2018, Journal of the American Society of Nephrology : JASN.

Initiating Dialysis at the Right Time: Is the Evidence IDEAL?

J. Berns, C. M. Chaknos, 2010, Seminars in dialysis.

NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative.

J. Adamson, A. Nissenson, J. Wish, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Native Kidney Biopsy: Update and Evidence for Best Practice.

J. Berns, Jonathan J. Hogan, Michaela Mocanu, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.

J. Berns, Jehan Z. Bahrainwala, 2016, Seminars in nephrology.

CHAPTER 58 – Use of Erythropoietic-Stimulating Agents in Hemodialysis Patients

J. Berns, A. Tsai, 2008 .

Review: angiotensin-converting enzyme inhibitors reduce the progression of non-diabetic renal disease

J. Berns, 2002, ACP journal club.

CLINICAL INTERVENTIONS TO REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH KIDNEY DISEASE

J. Berns, 2005 .

Opinion: How Should Chronic Medical Therapies be Altered with the Onset of End‐Stage Renal Disease and Initiation of Dialysis?

J. Berns, Karen M. Warburton, 2006 .

Bromfenac disposition in patients with impaired kidney function

M. Rudnick, J. Boni, R. Fruncillo, 1997, Clinical pharmacology and therapeutics.

Reviews: Should the Target Hemoglobin for Patients with Chronic Kidney Disease Treated with Erythropoietic Replacement Therapy be Changed?

J. Berns, 2005, Seminars in dialysis.

More May be Less; Yet Another Way which More Intense Renal Replacement Therapy May Not be Better

J. Berns, B. Besharatian, 2016, Seminars in dialysis.

Development, implementation, and results of the ASN in-training examination for fellows.

Q. Qian, S. Digiovanni, M. Rosner, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Performance of procedures by nephrologists and nephrology fellows at U.S. nephrology training programs.

W. C. O'Neill, J. Berns, W. O'Neill, 2008, Clinical journal of the American Society of Nephrology : CJASN.

25-Hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies report.

M. Rocco, H. Kramer, J. Berns, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

When chronic kidney disease becomes advanced

J. Berns, D. Kirk, A. Mosenkis, 2006, Postgraduate medicine.

Preventing bacterial infections and antimicrobial resistance in dialysis patients.

J. Tokars, J. Berns, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of darbepoetin alfa on endothelial progenitor cells and vascular reactivity in chronic kidney disease

E. Mohler, Elizabeth Medenilla, B. French, 2011, Vascular medicine.

Effect of Neighborhood Food Environment and Socioeconomic Status on Serum Phosphorus Level for Patients on Chronic Dialysis.

J. Shults, P. Reese, D. Wiebe, 2020, Journal of the American Society of Nephrology : JASN.

Rhabdomyolysis and acute renal failure following arthroscopic knee surgery in a college football player taking creatine supplements.

B. Sennett, N. Sheth, J. Berns, 2006, Clinical nephrology.

The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients

S. Fishbane, P. Deoreo, J. Berns, 2005, Hemodialysis international. International Symposium on Home Hemodialysis.

Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis

J. Berns, A. Mosenkis, 2005, Hemodialysis international. International Symposium on Home Hemodialysis.

Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth.

J. Berns, N. Siegel, L. Krassner, 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Training the next generation's nephrology workforce.

D. Ellison, S. Linas, M. Rosner, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists.

J. Berns, N. Kasbekar, 2005, Clinical journal of the American Society of Nephrology : CJASN.

Summary and Comment: Boning Up on Lanthanum

J. Berns, Sidney Korbin, 2006, Seminars in dialysis.

Progression of Orthostatic Proteinuria to Focal and Segmental Glomeruloscierosis

J. Berns, N. Siegel, K. Gaudio, 1986, Clinical pediatrics.

Nonsurgical cure of pulmonary mucormycosis.

M. Lederman, J. Berns, B. Greene, 1984, The American journal of the medical sciences.

The "Advancing American Kidney Health" Executive Order: Challenges and Opportunities for the Large Dialysis Organizations.

P. Ginsburg, G. Chertow, J. Berns, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Plasma oxalate levels in prevalent hemodialysis patients and potential implications for ascorbic acid supplementation.

C. Langman, K. Hunter, J. Berns, 2016, Clinical biochemistry.

Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

J. Berns, C. Hill, A. Bansal, 2015, Seminars in dialysis.

Use of Low Molecular Weight Heparins and Glycoprotein IIb/IIIa Inhibitors in Patients with Chronic Kidney Disease

M. Perazella, J. Berns, A. Mosenkis, 2004, Seminars in dialysis.

Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease

I. Macdougall, T. Akizawa, Hiroyasu Yamamoto, 2019, Nephron.

Erythropoietin and resistant hypertension in CKD.

J. Berns, S. Boyle, 2014, Seminars in nephrology.

Dabigatran and kidney disease: a bad combination.

M. Perazella, J. Berns, F. Knauf, 2013, Clinical journal of the American Society of Nephrology : CJASN.

HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: The Safety of Heparins in End‐Stage Renal Disease

J. Berns, N. Kasbekar, S. Sonawane, 2006, Seminars in dialysis.

Erratum: Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time (Kidney International (2005) 68 (2323-2330))

M. Joffe, H. Feldman, F. Port, 2005 .

Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.

M. Rudnick, R. Cohen, J. Berns, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Chapter 49 – Use of Erythropoiesis-Stimulating Agents in Hemodialysis Patients

J. Berns, B. A. Mohamed, 2017 .

Transforming Nephrology.

M. Rosner, J. Berns, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Extracorporeal Treatment of Cast Nephropathy

J. Berns, S. Kobrin, Bhavna Gakhar, 2011, Seminars in dialysis.

Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease.

M. Rudnick, R. Cohen, J. Berns, 1999, Kidney international.

Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients

M. Rudnick, J. Tomaszewski, Amir Haghighat, 1995, Cancer.

Summary and Comment: How Much Is Enough? The Impact of Frequent Hemodialysis

J. Berns, D. Negoianu, J. Glickman, 2008, Seminars in dialysis.

Spontaneous tumor lysis syndrome in acute myeloid leukemia: Two cases and a review of the literature

Erin M. Olson, A. Mato, S. Luger, 2006, Cancer biology & therapy.

Infection with Antimicrobial‐resistant Microorganisms in Dialysis Patients

J. Berns, 2003, Seminars in dialysis.

Conflicts of interest in dialysis: A barrier to policy reforms

J. Berns, Aaron Glickman, E. Lin, 2020, Seminars in dialysis.

Clinical Applications of Iron Management in Hemodialysis Patients

P. Deoreo, J. Berns, Peter B. DeOreo, 1999 .

Editorials: Niacin and Related Compounds for Treating Hyperphosphatemia in Dialysis Patients

J. Berns, 2008, Seminars in dialysis.

The ASN in-training examination needs more time, not a new paradigm.

J. Berns, 2010, Clinical journal of the American Society of Nephrology : CJASN.

SP309SAFETY AND EFFICACY OF MOLIDUSTAT IN ERYTHROPOIESIS STIMULATING AGENTS (ESA) PRE-TREATED ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (CKD-ND)

I. Macdougall, T. Akizawa, Thilo Krüger, 2016 .

SO036MOLIDUSTAT INCREASES HAEMOGLOBIN IN ERYTHROPOIESIS STIMULATING AGENTS (ESA)-NAIVE ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (CKD-ND)

I. Macdougall, T. Akizawa, J. Berns, 2016 .

A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.

M. Rudnick, R. Cohen, J. Berns, 1992, Clinical nephrology.

Is Hemodialysis Bad for the Heart?

J. Berns, Jen-Shiung Lin, 2012, Seminars in dialysis.

Should all patients with chronic kidney disease receive an EPO-type drug?

J. Berns, 2006, Cleveland Clinic journal of medicine.

Dialysis-Facility Joint-Venture Ownership - Hidden Conflicts of Interest.

J. Berns, Aaron Glickman, Matthew S McCoy, 2018, The New England journal of medicine.

28 – Viral Nephropathies: Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus

L. Mariani, J. Berns, 2013 .

Nutritional Management of Chronic Kidney Disease.

J. Berns, 2018, The New England journal of medicine.

Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases.

R. Cohen, J. Berns, M. Silverman, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Do oral iron supplements have any role in dialysis patients?

L. Mariani, J. Berns, 2011, Seminars in dialysis.

Red Blood Cell Transfusion Risks in Patients with End‐Stage Renal Disease

Y. Tanhehco, J. Berns, 2012, Seminars in dialysis.

Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)

F. Wilson, J. Berns, 2011, Clinical nephrology.

An Open Letter to HHS Secretary Burwell on Ethically Increasing Organ Donation.

J. Bonventre, D. Brennan, R. Blantz, 2015, Transplantation direct.

Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.

M. Rudnick, R. Cohen, J. Berns, 1991, Journal of the American Society of Nephrology : JASN.

Renal toxicities of antineoplastic drugs and bone marrow transplantation.

J. Berns, P. Ford, 1997, Seminars in nephrology.

Use of Antiepileptic Drugs in Patients with Kidney Disease

K. Haynes, Rubeen K. Israni, J. Berns, 2006, Seminars in dialysis.

Studies of a family with incontinentia pigmenti variably expressed in both sexes.

J. Berns, T. Kurczynski, W. Johnson, 1982, Journal of medical genetics.

Measuring Vitamin, Mineral, and Trace Element Levels in Dialysis Patients

J. Berns, Hesham Shaban, Muhammad Ubaid-Ullah, 2014, Seminars in dialysis.

Cancer and the kidney: the growth of onco-nephrology.

M. Perazella, M. Rosner, J. Berns, 2014, Advances in chronic kidney disease.

Onco-nephrology: tumor lysis syndrome.

F. Wilson, J. Berns, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Notice

J. Adamson, J. McMurray, I. Macdougall, 2012, Kidney International Supplements.

Hematologic Complications of Chronic Kidney Disease—Anemia and Platelet Disorders

J. Berns, Sarah J. Schrauben, 2020 .

Hematologic Complications of Chronic Kidney Disease

J. Berns, 2015 .

KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease

J. Adamson, I. Macdougall, P. Parfrey, 2012 .

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

D. Vlahov, P. Kimmel, C. Winkler, 2008, Nature Genetics.

Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population.

D. Vlahov, K. Goddard, P. Kimmel, 2005, Physiological genomics.

Tumor lysis syndrome: new challenges and recent advances.

F. Wilson, J. Berns, F. Perry Wilson, 2014, Advances in chronic kidney disease.

Kidney diseases associated with haematological cancers

J. Berns, D. Sawinski, A. Ganguli, 2015, Nature Reviews Nephrology.

Normal splenic function in children with the nephrotic syndrome

J. Berns, H. Pearson, N. Siegel, 1988, Pediatric Nephrology.

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Giulio Genovese, Sophie Limou, Howard Trachtman, 2011, Journal of the American Society of Nephrology : JASN.

Contrast media-associated nephrotoxicity.

M. Rudnick, S. Goldfarb, R. Cohen, 1996, Current opinion in nephrology and hypertension.

Hemoglobin variability in epoetin-treated hemodialysis patients.

S. Fishbane, P. Deoreo, J. Berns, 2003, Kidney international.

NPHS2 variation in sporadic focal segmental glomerulosclerosis.

P. Kimmel, C. Winkler, M. Cho, 2007, Journal of the American Society of Nephrology : JASN.

Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee.

Timothy J Wilt, Gordon H Guyatt, Katrin Uhlig, 2016, Kidney international.

Routine screening for CKD should be done in asymptomatic adults... selectively.

J. Berns, Jeffrey S Berns, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Viral nephropathies: core curriculum 2008.

R. Bloom, J. Berns, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies

I. Macdougall, T. Akizawa, K. Iekushi, 2019, American Journal of Nephrology.

Clinical Decision Making in a Patient with Stage 5 CKD--Is eGFR Good Enough?

J. Berns, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Demographics of Kidney Disease

H. Feldman, A. Anderson, J. Berns, 2012 .

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.

J. Berns, Jeffrey S. Berns, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

MYH 9 is a major-effect risk gene for focal segmental glomerulosclerosis

D. Vlahov, P. Kimmel, C. Winkler, 2008 .

Anemia in Chronic Kidney Disease

J. Berns, S. Dawson, Tiffany C. L. Wong, 2019, Chronic Kidney Disease, Dialysis, and Transplantation.

Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients.

A. Nissenson, J. Berns, P. Seligman, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Onco-nephrology: what the nephrologist needs to know about cancer and the kidney.

M. Rosner, J. Berns, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Interpretation of the Kidney Disease: Improving Global Outcomes guidelines for iron therapy: commentary and emerging evidence

J. Berns, 2017, Clinical kidney journal.

Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials.

S. Goldfarb, T. Imperiale, J. Berns, 1995, Journal of the American Society of Nephrology : JASN.

Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time.

Harold I Feldman, Marshall M Joffe, M. Joffe, 2005, Kidney international.

Training Nephrology Fellows in Temporary Hemodialysis Catheter Placement and Kidney Biopsies is Needed and Should be Required.

J. Berns, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Vitamin Needs of the Predialysis Patient

J. Berns, 1997 .

Contrast Media in Dialysis Patients: Should We Be More Concerned?

M. Rudnick, R. Cohen, J. Berns, 1998 .

Chronic kidney disease in patients with renal cell carcinoma.

A. Finelli, M. Rosner, A. Chang, 2014, Advances in chronic kidney disease.

Complications of Percutaneous Treatment of Thrombosed Hemodialysis Access Grafts

S. Ash, J. Berns, F. Weng, 2003, Seminars in dialysis.

Hypoglycemia with hyperinsulinemia in a chronic hemodialysis patient following parathyroidectomy.

M. Rudnick, R. Cohen, J. Berns, 1992, Nephron.

Single-center experience with the Arrow-Trerotola Percutaneous Thrombectomy Device in the management of thrombosed native dialysis fistulas.

S. Stavropoulos, J. Mondschein, R. Shlansky-Goldberg, 2005, Journal of vascular and interventional radiology : JVIR.

Duplication 6q syndrome.

J. Berns, W. Johnson, R. Summitt, 1979, American journal of medical genetics.

A SHARP Study, But With Blunted Conclusions

J. Berns, 2011, Seminars in dialysis.

Recruitment of live donors by candidates for kidney transplantation.

Harold I Feldman, Marshall M Joffe, Judy A Shea, 2008, Clinical journal of the American Society of Nephrology : CJASN.

APOL 1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy

D. Vlahov, P. Kimmel, C. Winkler, 2011 .

KDOQI in the era of global guidelines.

M. Rocco, J. Berns, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association Between Nephrologist Ownership of Dialysis Facilities and Clinical Outcomes.

J. Berns, Matthew S McCoy, Manqing Liu, 2022, JAMA internal medicine.

Management of Anemia in Chronic Kidney Disease

J. Berns, B. Abramovitz, 2020, Chronic Renal Disease.

Response to time to consider the role of epoetin

M. Joffe, H. Feldman, F. Port, 2006 .

Summary and Comment: Hemoglobin Variability: Random Fluctuation, Epiphenomenon, or Phenomenon?

S. Fishbane, J. Berns, 2006 .

Hemoglobin variability: random fluctuation, epiphenomenon, or phenomenon?

S. Fishbane, J. Berns, Jeffrey S Berns, 2006, Seminars in dialysis.

CPR for OHCA Is Rarely Successful, and What Is "Success" Anyway?

J. Berns, N. Eneanya, Samantha L. Gelfand, 2019, Journal of the American Society of Nephrology : JASN.

History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients.

M. Joffe, H. Feldman, S. Fishbane, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Creatinine generation is reduced in patients requiring continuous venovenous hemodialysis and independently predicts mortality.

F. Wilson, L. Mariani, J. Berns, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Selection and Dosing of Medications for Management of Diabetes in Patients with Advanced Kidney Disease

James B Reilly, J. Berns, Jeffrey S Berns, 2010, Seminars in dialysis.

KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

Katrin Uhlig, Mary B Leonard, B. Kestenbaum, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Quality training, quality board examinations, quality nephrologists.

T. Ikizler, J. Berns, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

International Medical Graduates in Nephrology: Roles, Rules, and Future Risks.

J. Berns, M. Ghosn, Rodolfo R Altamirano, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nephrology in the Academic Intensive Care Unit: A Qualitative Study of Interdisciplinary Collaboration.

L. Fleisher, M. Curley, M. Lane-Fall, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests: The PRICE Randomized Clinical Trial

Dylan S. Small, Dylan S Small, Jennifer S Myers, 2017, JAMA internal medicine.

Inherited hemolytic uremic syndrome in adults.

J. Berns, B. Kaplan, R. Mackow, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients.

N. Powe, B. Astor, B. Jaar, 2004, Kidney international.

Impact of tip culture on the management of infected tunneled hemodialysis catheters.

S. Trerotola, R. Cohen, J. Berns, 2007, Journal of vascular and interventional radiology : JVIR.

Staphylococcus-Infected Tunneled Dialysis Catheters: Is Over-the-Wire Exchange an Appropriate Management Option?

Jessica M. Langer, S. Trerotola, J. Chittams, 2011, CardioVascular and Interventional Radiology.

Handoff communication between hospital and outpatient dialysis units at patient discharge: a qualitative study.

J. Shea, J. Berns, L. Marcotte, 2013, Joint Commission journal on quality and patient safety.

The impact of documentation of severe acute kidney injury on mortality

H. Feldman, F. Wilson, B. Fuchs, 2013, Clinical nephrology.

Dialysis versus nondialysis in patients with AKI: a propensity-matched cohort study.

H. Feldman, F. Wilson, L. Mariani, 2014, Clinical journal of the American Society of Nephrology : CJASN.

False-Positive Rate of AKI Using Consensus Creatinine-Based Criteria.

F. Wilson, C. Parikh, J. Berns, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Removal of myoglobin by CAVH-D in traumatic rhabdomyolysis.

M. Rudnick, R. Cohen, J. Berns, 1991, American journal of nephrology.

A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD.

R. Toto, M. Weir, J. Berns, 2020, Journal of the American Society of Nephrology : JASN.

Analysis of Performance Trends from 2010–2019 on the American Board of Internal Medicine Nephrology Certifying Exam

B. Jaar, R. Lipner, F. McDonald, 2021, Journal of the American Society of Nephrology : JASN.

A decade after the KDOQI CKD guidelines: impact on NKF-KDOQI.

M. Rocco, J. Nally, H. Kramer, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

DIALYSIS CLINIC: Is Intravenous Iron Safe in Patients With Liver Disease?

J. Berns, 2002 .

Disorders of Magnesium Homeostasis

J. Berns, 2009 .

Contrast media-associated nephrotoxicity.

M. Rudnick, S. Goldfarb, R. Cohen, 1997, Seminars in Nephrology.

Reviews: Use of Insulin and Oral Hypoglycemic Medications in Patients with Diabetes Mellitus and Advanced Kidney Disease

J. Berns, Richard W. Snyder, Jeffrey S. Berns, 2004, Seminars in dialysis.

Willingness of patients to switch from conventional to daily hemodialysis: looking before we leap.

A. Israni, S. Halpern, J. Berns, 2004, The American journal of medicine.

Transparency as a Trust-Building Practice in Physician Relationships With Patients.

C. Braddock, J. Berns, Tara Montgomery, 2020, JAMA.

Quinine—A Tonic Too Bitter for Hemodialysis‐Associated Muscle Cramps?

J. Berns, S. Kobrin, 2007, Seminars in dialysis.

What is the nephrologist's role as a primary care provider? We all have different answers.

L. Szczech, J. Berns, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Reflections on a Crisis in Graduate Medical Education: The Closure of Hahnemann University Hospital.

J. Berns, D. Paskin, A. Spevetz, 2020, Academic medicine : journal of the Association of American Medical Colleges.

Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis.

A. Israni, S. Halpern, Rubeen K. Israni, 2004, Kidney international.

Risk of complications with use of aspirin during renal biopsy: A systematic review.

C. Umscheid, J. Berns, Vinayak Kumar, 2018, Clinical nephrology.

Predictors of Having a Potential Live Donor: A Prospective Cohort Study of Kidney Transplant Candidates

M. Joffe, H. Feldman, P. Reese, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

What Is the Role of Daprodustat in Treatment of Anemia in People on Maintenance Dialysis?

J. Berns, 2023, American Society of Nephrology. Clinical Journal.

Drug prescribing in renal failure: dosing guidelines for adults.

M Wolfson, G Morrison, M. Brier, 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Celebrating 4 Decades of AJKD.

H. Feldman, J. Berns, L. Dember, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists.

J. Berns, N. Kasbekar, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Honoring Patient Preferences: The 2016 National Kidney Foundation Presidential Address.

J. Berns, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Summary and Comment: Arterial Stiffness and Vascular Calcification in Dialysis Patients: New Measures of Cardiovascular Risk

J. Berns, S. Deloach, 2007, Seminars in dialysis.

28 – Viral Nephropathies: Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus

L. Mariani, J. Berns, 2013 .

Can frequent hemodialysis be too frequent?

J. Berns, L. Dember, 2013, Journal of the American Society of Nephrology : JASN.

A survey-based evaluation of self-perceived competency after nephrology fellowship training.

J. Berns, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Addressing the Nephrology Workforce Shortage Via a Novel Undergraduate Pipeline Program: The Kidney Disease Screening and Awareness Program (KDSAP) at ten years.

L. Hsiao, E. Krupat, S. S. Mothi, 2021, Kidney international.

KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

B. Kestenbaum, K. Uhlig, M. Leonard, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Improving Care of Patients With CKD: The 2015 National Kidney Foundation Presidential Address.

J. Berns, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Blueprint for Increasing Ethnic and Racial Diversity in U.S. Residency Training Programs

I. Rosen, Elana A. Meer, J. Berns, 2022, Academic medicine : journal of the Association of American Medical Colleges.

The renal manifestations of thyroid disease.

L. Mariani, J. Berns, 2012, Journal of the American Society of Nephrology : JASN.

NPHS2 variation in sporadic focal segmental glomerulosclerosis.

P. Kimmel, C. Winkler, L. Mckenzie, 2007, Journal of the American Society of Nephrology.

Summary and Comment: Erythropoietin Bundling: Innovative Remuneration or the Dawn of EPO‐Profiling?

J. Berns, Gbemisola A. Adeseun, 2010, Seminars in dialysis.

Summary and Comment: Impact of Obstructive Sleep Apnea in Hemodialysis Patients

J. Berns, S. Deloach, 2009, Seminars in dialysis.

Renal and urologic aspects of HIV infection

P. Kimmel, J. Berns, 1995 .

Transforming Nephrology.

M. Rosner, J. Berns, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Should Nephrology Training Programs Continue to Train Fellows in the Placement of Temporary Hemodialysis Catheters?

J. Berns, D. Negoianu, 2014, Seminars in dialysis.

Low Cefepime Concentrations during High Blood and Dialysate Flow Continuous Venovenous Hemodialysis

F. Wilson, D. Fish, J. Berns, 2012, Antimicrobial Agents and Chemotherapy.

Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists.

J. Berns, N. Kasbekar, 2005, Clinical journal of the American Society of Nephrology : CJASN.

Home Dialysis Training Needs for Fellows: A Survey of Nephrology Program Directors and Division Chiefs in the United States

J. Perl, J. Berns, S. Bansal, 2023, Kidney medicine.

Clinical Decision Making in a Patient with Stage 5 CKD--Is eGFR Good Enough?

J. Berns, 2015, Clinical journal of the American Society of Nephrology : CJASN.